Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  CGC | T.WEED.DB

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Post by Seaniganon Sep 17, 2016 7:42pm
364 Views
Post# 25248905

Looking forward

Looking forward Excellent post by Doobiebaby. I think investors need to try and look forward to what's to come. The biggest problem that I have been seeing and I know a lot of investors have mentioned is supply. 

I have a relative that that works for one of the aggregators (company who sets up clients with a med license and LP). She mentioned that there is a huge problem with inventories right now. Clients are furious when they rely on a strain and cannot get it due to shortages. She said that their clinic recommended Bedrocan/Tweed most often because they always have stock. I think as this market continues to grow the smaller LP will overextend themselves and burn many bridges with their customers. Good ole faithful CGC will be there to help those customers in need of medicine. I know everyone is doing their best to rapidly expand and keep up. Fortunately for us CGC shareholders, we had a healthy head start and spent more than all the others expanding early so we would be ready for this influx. My cousin also mentioned clients really likes Bedrocan's $5 compassionate pricing across the board no matter the strain. It took the confusion of out picking medicine. 

She cant believe how overbooked her work is with people trying to get signed up. She said there are lineups all day, everyday. The doctors and do the consults much faster than the admin staff can process the clients, so people are forced to wait up to 2 hours during the process. It's very frustrating for all involved. She said the ages she deals with varies from 20-100 year olds with the vast majority being seniors who have no other options to try. This surprised me. I figured there would be lots of younger people trying to legitimize a pot habit. Apparently a lot of those are turned down and the older generations with serious medical needs make up the bulk of MJ licenses. Great to hear.

All in all it sounds like the customer base for the industry continues to grow at an exponential rate. If rec does take longer to begin I think CGC will do MUCH better than others as their company/brand/reliability is MUCH stronger than most. COMA in general will have the endurance to survive delays with the strength of med. Its the smaller/newer LPs that will suffer as they are so far behind already. They will need rec to have their boats rise with the tide. Any delays and they will be hurting. 

Pumped to to see how this next year plays out for CGC. Again, I think investors need to look forward to where the problems and solutions will be found in the future. CGC is ready now and is well funded (with the ability to raise with less dilution). Not to mention the potential customer expansion when other countries progress with their respective MJ legislation. Linton's foresight will pay off in spades.

CGC has been pretty stagnant this last 2 months. I was definitely one of the many that took my money elsewhere and made a killing. But today I can't find the obvious value play anymore. Everyone is overvalued and at all time highs. Not to say they won't go higher, I just don't like the uncertainty. CGC has had its time to consolidate and now it will start its own run heading into Oct/Nov. Once we eclipse the $5 mark this stock should have take off as the only viable option for big money to enter. Love hearing Bruce has been talking to some Wall Street types. 

I could go on haha. Move ahead of the pack and reap the rewards. 


Bullboard Posts